How Do You Help Your EGFR Patients Make Treatment Decisions When Their Cancers Grow? – Video


How Do You Help Your EGFR Patients Make Treatment Decisions When Their Cancers Grow?
Dr. Geoffrey Oxnard from Harvard Medical School talks about EGFR treatment decisions, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity...

By: Oncology.TV

Read this article:
How Do You Help Your EGFR Patients Make Treatment Decisions When Their Cancers Grow? - Video

Molecular Testing for Early Stage Lung Cancer Patients – Is it Necessary? – Video


Molecular Testing for Early Stage Lung Cancer Patients - Is it Necessary?
Dr. Joel Neal from Stanford University Medical School talks about molecular testing, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity...

By: Oncology.TV

Original post:
Molecular Testing for Early Stage Lung Cancer Patients - Is it Necessary? - Video

Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC? – Video


Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC?
Dr. Joel Neal from Stanford University Medical School talks about erlotinib, filmed at IASLC in February 2014. Oncology.TV would like to acknowledge CancerGrace.org and the Lungevity Foundation...

By: Oncology.TV

Visit link:
Will Erlotinib Prevent Disease Recurrence in Patients with Early Stage EGFR Positive NSCLC? - Video

What’s the Status and Potential Utility of Cabozantinib in Lung Cancer? – Video


What #39;s the Status and Potential Utility of Cabozantinib in Lung Cancer?
Dr. Heather Wakelee from Stanford University Medical School talks about the status and potential utility of cabozantinib in lung cancer, filmed at IASLC in February 2014. Oncology.TV would...

By: Oncology.TV

Continued here:
What's the Status and Potential Utility of Cabozantinib in Lung Cancer? - Video

How "Hide and Play Dead" Makes Headlines: PART THREE, CONTINUED – Video


How "Hide and Play Dead" Makes Headlines: PART THREE, CONTINUED
The nature of educational elitism, thwarted by my parents #39; plots against my uniqueness, and my inside story of the medical field in the late 70 #39;s and early 80 #39;s, is riveting and naturally raises...

By: Michael King

See the rest here:
How "Hide and Play Dead" Makes Headlines: PART THREE, CONTINUED - Video